Fewer than 10% of patients in England who are eligible will initially be able to access it on the NHS.
Source link : https://www.independent.co.uk/life-style/health-and-families/nhs-medicines-and-healthcare-products-regulatory-agency-england-national-institute-for-health-and-care-excellence-type-2-diabetes-b2659341.html
Author : Camilla Foster
Publish date : 2024-12-05 10:50:51
Copyright for syndicated content belongs to the linked Source.
The ‘King Kong of weight-loss drugs’ – what is Mounjaro and who will be eligible for it?
